2012
DOI: 10.1007/s00467-012-2248-z
|View full text |Cite
|
Sign up to set email alerts
|

DNA methylation changes between relapse and remission of minimal change nephrotic syndrome

Abstract: Background DNA methylation of gene promoters is associated with transcriptional inactivation. Changes in DNA methylation can lead to differences in gene expression levels and thereby influence disease development. We hypothesized that epigenetics underlies the pathogenesis of minimal change nephrotic syndrome (MCNS). Methods Genome-wide DNA methylation changes between relapse and remission in monocytes (n06) and naive T helper cells (Th0s) (n04) isolated from patients with MCNS were investigated using the micr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 16 publications
(20 citation statements)
references
References 35 publications
2
18
0
Order By: Relevance
“…Pyrosequencing was performed to assess quantitative DNA methylation at CpG sites as previously described . Bisulfite treatment of DNA converts non‐methylated cytosine to uracil, which is recognized as thymine by Taq polymerase, whereas methylated cytosine remains cytosine.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Pyrosequencing was performed to assess quantitative DNA methylation at CpG sites as previously described . Bisulfite treatment of DNA converts non‐methylated cytosine to uracil, which is recognized as thymine by Taq polymerase, whereas methylated cytosine remains cytosine.…”
Section: Methodsmentioning
confidence: 99%
“…Pyrosequencing was performed to assess quantitative DNA methylation at CpG sites as previously described. 22 Bisulfite treatment of DNA converts non-methylated cytosine to uracil, which is recognized as thymine by Taq polymerase, whereas methylated cytosine remains cytosine. Bisulfitetreated DNA was amplified with 0.2 μM 'WT1-promoteruniv-F' primer, 0.18 μM 'Biotinylated Universal' primer, 0.02 μM 'R-adaptor' primer and Platinum PCR SuperMix High Fidelity (Invitrogen).…”
Section: Pyrosequencingmentioning
confidence: 99%
“…A genome-wide DNA methylation array analysis was performed using the microarray-based integrated analysis of methylation by isochizomers (MIAMI) method, as previously described ( Hatada et al , 2006 ; Horii et al , 2009 ; Kobayashi et al , 2012 ). In brief, this method utilises two isochizomers, Hpa II and Msp I, which recognise the same DNA sequence (CCGG).…”
Section: Methodsmentioning
confidence: 99%
“…Human fetal (male 18 and 22 weeks and female 18 weeks after fertilization) and adult (male 20, 44, and 59 years old) liver genomic DNAs were purchased from BioChain Institute Inc. (Newark, CA). The Microarray-Based Integrated Analysis of Methylation by Isoschizomers (MIAMI) analysis, a genomewide analysis of DNA methylation using a gene promoter array and methylation-sensitive restriction enzyme, was performed as described (20)(21)(22). Detailed experimental procedure is described in the Supplementary Data.…”
Section: Dna Methylation Profilingmentioning
confidence: 99%